Lead sponsor
University of California, Davis
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
1
Active
8
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Not applicable
1
Trials by status
Active, not recruiting
1
Terminated
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist UsersBMI ≥30not applicableActive, not recruiting7